Company / Operating Cash Flow per Share
Eledon Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.93
FY2016
5-year range
-$18.92 / -$0.69
FY2014-FY2016
Trend
-35.2%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-18.92 to $-0.93 over the past 2 years.
Based on SEC 10-K filings.
-0.93 in FY2016.
Improved from $-18.92 to $-0.93 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, operating cash flow per share decreased 35.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | -$0.93 | -35.2% |
| FY2015 | -$0.69 | +96.3% |
| FY2014 | -$18.92 | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026